Awardees of the Spring selection of YY Study Grants

12 September 2017

UICC and the JAPAN NATIONAL COMMITTEE for UICC are pleased to announce 4 Awardees of the 2017 Spring Selection of Yamagiwa-Yoshida Memorial International Cancer Study Grants (YY).

The 4 researchers awarded YY Study grants are from the United States, Italy, France and the United Kingdom, and will go to Denmark and the United States for their 3 month research projects. The topics covered include the gut microbiome, roles of tumor suppressors in 3D organisation of the genome and apoptosis, and tumor microenvironment. For more information on the awardees' projects, please see below.

The second call for proposals is now open until October 15, please click here for details on how to apply.

Quotes from the Awardees:

"I am grateful for this opportunity to learn from internationally known experts in pharmacoepidemiology at the Aarhus University Hospital, and work with them on an exciting project that will contribute to our understanding of the possible roles of the gut microbiome and medications that alter its composition and diversity in colon cancer progression". Dr Fedirko,  Emory University,  Atlanta, USA

“At the University of Hawaii Cancer Center, I will conduct investigations to develop novel therapies and preventive approaches for mesothelioma, malignant cancer caused by asbestos. Recently, we discovered a specific genetic mechanism that makes mesothelioma cells resistant to chemotherapy. Thanks to the study grant award, I will now work to find the way to repair these genetic alterations." Dr Giorgi, University of Ferrara, ​Italy

“It's a great opportunity for me to meet new people, improve my skills and discuss ideas. It will definitely help our ongoing projects on glioblastoma to go further.” Dr Simon, University of Sussex, United Kingdom

"I am excited to receive this study grant to go to Stanford University. It will allow me to further extend my research into how the p53 protein, one of the most commonly mutated tumor suppressors, contributes to the 3D organization of the genome.” Dr Le Cam, INSERM, Montpellier, France

Last update: 
Tuesday 19 September 2017
Share